Literature DB >> 11145969

Impaired thrombin generation in beta 2-glycoprotein I null mice.

Y Sheng1, S W Reddel, H Herzog, Y X Wang, T Brighton, M P France, S A Robertson, S A Krilis.   

Abstract

Autoimmune antibodies to beta(2)-glycoprotein I (beta2GPI) have been proposed to be clinically relevant because of their strong association with thrombosis, miscarriage, and thrombocytopenia. By using a homologous recombination approach, beta2GPI-null mice were generated to begin to understand the physiologic and pathologic role of this prominent plasma protein in mammals. When beta2GPI heterozygotes on a 129/Sv/C57BL/6 mixed genetic background were intercrossed, only 8.9% of the resulting 336 offspring possessed both disrupted alleles. These data suggest that beta2GPI plays a beneficial role in implantation and/or fetal development in at least some mouse strains. Although those beta2GPI-null mice that were born appeared to be relatively normal anatomically and histologically, subsequent analysis revealed that they possessed an impaired in vitro ability to generate thrombin relative to wild type mice. Thus, beta2GPI also appears to play an important role in thrombin-mediated coagulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145969     DOI: 10.1074/jbc.M010990200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Pathogenic role of antiphospholipid antibodies.

Authors:  J E Salmon; P G de Groot
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

2.  Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

Authors:  Miri Blank; Ilan Krause; Mati Fridkin; Nathan Keller; Juri Kopolovic; Iris Goldberg; Ana Tobar; Yehuda Shoenfeld
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  New insights into the biology and pathobiology of beta2-glycoprotein I.

Authors:  Bill Giannakopoulos; Peyman Mirarabshahi; Steven A Krilis
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

4.  Increased thrombosis susceptibility and altered fibrin formation in STAT5-deficient mice.

Authors:  Sarah M Nordstrom; Brian A Holliday; Brandon C Sos; James W Smyth; Robert E Levy; Jonathan W Dukes; Susan T Lord; Ethan J Weiss
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

5.  β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

Authors:  Ariela Arad; Valerie Proulle; Richard A Furie; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

6.  beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.

Authors:  Chunya Bu; Lei Gao; Weidong Xie; Jainwei Zhang; Yuhong He; Guoping Cai; Keith R McCrae
Journal:  Arthritis Rheum       Date:  2009-02

7.  Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.

Authors:  Tong Shi; G Michael Iverson; Jian C Qi; Keith A Cockerill; Matthew D Linnik; Pamela Konecny; Steven A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

Review 8.  The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it?

Authors:  Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

9.  Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.

Authors:  Alexey Kolyada; Andrew Porter; Natalia Beglova
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

10.  Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.

Authors:  Hsueh-Hsiao Wang; An-Na Chiang
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.